Search results for "pharmaceutical company"

Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?

Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?

A Reuters report said the U.K. media outlet The Guardian reported on the 19th (20th in Korea time) that the World Health Organization is considering...
Daewoong Pharmaceutical Acquires U.S. Cellular Reprogramming Tech to Fast-Track Anti-Aging Therapeutics

Daewoong Pharmaceutical Acquires U.S. Cellular Reprogramming Tech to Fast-Track Anti-Aging Therapeutics

Daewoong Pharmaceutical is accelerating its research and development into anti-aging therapeutics. The company announced on the 21st that it has...
When Recurrent Diarrhea Is More Than a Passing Bug: The Rising Threat of IBD in Young Adults

When Recurrent Diarrhea Is More Than a Passing Bug: The Rising Threat of IBD in Young Adults

When recurring abdominal pain and diarrhea strike, most people first assume they are dealing with a standard bout of...
Rejuran Cosmetics Sales Surge 51%: PharmaResearch Finds New Growth Engine

Rejuran Cosmetics Sales Surge 51%: PharmaResearch Finds New Growth Engine

PharmaResearch is successfully diversifying its business model, transitioning from a medical device-centric structure...
Seizure- and Recurrence-Prone Glioma: First New Drug in 20 Years

Seizure- and Recurrence-Prone Glioma: First New Drug in 20 Years

Being diagnosed with a brain tumor in your 30s or 40s—when you are building your career, raising children, and staying...
Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection

Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection

Daewoong Pharmaceutical is teaming up with a biotech startup to develop an obesity treatment administered by injection...
K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge

K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge

More than 10 South Korean pharmaceutical companies are pivoting toward veterinary medicine as a strategic growth engine.
A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions

A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions

Truxima , a blood cancer treatment developed by Celltrion, has become the first Korean-made biosimilar to rank number...
Will Curocell’s First CAR-T Blood Cancer Drug Secure Approval Next Month?

Will Curocell’s First CAR-T Blood Cancer Drug Secure Approval Next Month?

A final decision on the approval of RIMQARTO (anbalcabtagene autoleucel), a chimeric antigen receptor T-cell (CAR-T)...
“We Can’t Afford Dad's Medicine”: The Heartbreaking Reality of Late-Stage Cancer Costs

“We Can’t Afford Dad's Medicine”: The Heartbreaking Reality of Late-Stage Cancer Costs

“Should we sell the house? Dad’s medication is just too expensive.” This is the agonizing question keeping a mother in...